Title
Request for information - E60PH-28MPIV - Pandemic Influenza Vaccine Readiness and Supply Strategy
Reference number
WS5703210526-Doc5755485593
Solicitation number
WS5703210526
Publication date
2026-06-22
Tender closing date
2026-08-14T14:00:00
Expected contract start date
2028-04-01
Unspsc description
*Drugs and Pharmaceutical Products
Notice type
Request for Information
Procurement method
Competitive - Open bidding
Selection criteria
Variations or combinations of the above methods
Limited tendering reason
None
Trade agreements
*Canada-Panama Free Trade Agreement
*Canada-Chile Free Trade Agreement (CCFTA)
*Canada-Honduras Free Trade Agreement
*Canadian Free Trade Agreement (CFTA)
*Canada-UK Trade Continuity Agreement (Canada-UK TCA)
*Canada-Peru Free Trade Agreement (CPFTA)
*Canada-Colombia Free Trade Agreement
*Canada-Ukraine Free Trade Agreement (CUFTA)
*Canada-European Union Comprehensive Economic and Trade Agreement (CETA)
*Comprehensive and Progressive Agreement for Trans-Pacific Partnership (CPTPP)
*Canada-Korea Free Trade Agreement (CKFTA)
*World Trade Organization Agreement on Government Procurement (WTO GPA)
Regions of delivery
*Canada
Contracting entity name
Department of Public Works and Government Services (PSPC)
Contracting entity address line
11 Laurier St, Phase III, Place du Portage
Contracting entity address city
Gatineau
Contracting entity address province
Quebec
Contracting entity address postal code
K1A 0S5
Contracting entity address country
Canada
End user entities name
Public Health Agency of Canada (PHAC)
End user entities address
130 Colonnade Road,Ottawa,Ontario,K1A 0K9,Canada
Contact info name
Wijaya Putri, Yessica Karnali (SPAC/PSPC) (elle-la / she-her)
Contact info email
yessicakarnali.wijayaputri@tpsgc-pwgsc.gc.ca
Notice u r l
https://portal.us.bn.cloud.ariba.com/dashboard/public/appext/comsapsbncdiscoveryui#/RfxEvent/preview/1110016663?anId=ANONYMOUS
Tender description
Canada has a requirement for Pandemic Influenza Vaccine (PIV) readiness and supply to secure sufficient production capacity for up to 110 million doses of a monovalent PIV. To support the development of these requirements, Canada is seeking input from suppliers with a potential interest in bidding on future PIV Readiness and Supply contract(s), to address Canada’s medium- and/or long-term PIV readiness and supply needs.
